Catalyst Wire Dossier Catalyst Wire Dossier

Valsartan/Hydrochlorizide

Valsartan/Hydrochlorizide · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Valsartan/Hydrochlorizide, covering 2023-10-18 to 2023-10-18. Get the full timeline:

Most recent: Clinical Trial Update: VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil [Phase 3]

See pricing